Expert Opinion on Therapeutic Targets, Volume 26, Issue 6 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Therapeutic Targets, Volume 26, Issue 6 (2022)

See all volumes and issues
Vol 28, 2024 Vol 27, 2023 Volume 26, 2022 Vol 25, 2021 Vol 24, 2020 Vol 23, 2019 Vol 22, 2018 Vol 21, 2017 Vol 20, 2016 Vol 19, 2015 Vol 18, 2014 Vol 17, 2013 Vol 16, 2012 Vol 15, 2011 Vol 14, 2010 Vol 13, 2009 Vol 12, 2008 Vol 11, 2007 Vol 10, 2006 Vol 9, 2005 Vol 8, 2004 Vol 7, 2003 Vol 6, 2002 Vol 5, 2001 Vol 5, 2001 Vol 4, 2000 Vol 3, 1999 Vol 2, 1998 Vol 1, 1997
Download citations Download PDFs Download issue

Editorial

Editorial
IL-36: a therapeutic target for ulcerative colitis?
Yasmina E. Hernandez Santana, Naoise Irwin & Patrick T. Walsh
Pages: 507-512
Published online: 02 Jun 2022
First Page PreviewforIL-36: a therapeutic target for ulcerative colitis? | Full Text | References | PDF (540.6 KB) | EPUB
  • 1762 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Perspective

Article
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress
Ernestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, Antonino Belfiore, Marcello Maggiolini & Rosamaria Lappano
Pages: 513-535
Published online: 06 Jul 2022
AbstractforTriple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress | Full Text | References | PDF (2 MB) | EPUB
  • 308 Views
  • 4 CrossRef citations
  • 0Altmetric

Review

Leucine-rich repeat kinase 2 (LRRK2): an update on the potential therapeutic target for Parkinson’s disease
Jillian H. Kluss, Patrick A. Lewis & Elisa Greggio
Pages: 537-546
Published online: 02 Jun 2022
AbstractforLeucine-rich repeat kinase 2 (LRRK2): an update on the potential therapeutic target for Parkinson’s disease | Full Text | References | PDF (2.7 MB) | EPUB
  • 2980 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Acute myeloid leukemia: therapeutic targeting of stem cells
Cindy M. Pabon, Hussein A. Abbas & Marina Konopleva
Pages: 547-556
Published online: 02 Jun 2022
AbstractforAcute myeloid leukemia: therapeutic targeting of stem cells | Full Text | References | PDF (1.5 MB) | EPUB
  • 616 Views
  • 2 CrossRef citations
  • 0Altmetric
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets
Alberto Zambelli, Riccardo Sgarra, Rita De Sanctis, Elisa Agostinetto, Armando Santoro & Guidalberto Manfioletti
Pages: 557-573
Published online: 08 Jun 2022
AbstractforHeterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets | Full Text | References | PDF (4.5 MB) | EPUB
  • 290 Views
  • 3 CrossRef citations
  • 0Altmetric
TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target
Yara Al Ojaimi, Audrey Dangoumau, Hugo Alarcan, Rudolf Hergesheimer, Patrick Vourc’h, Philippe Corcia, Débora Lanznaster & Hélène Blasco
Pages: 575-592
Published online: 02 Jun 2022
AbstractforTAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target | Full Text | References | PDF (2.9 MB) | EPUB | Supplemental
  • 534 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles